DK112191B - Fremgangsmåde til fremstilling af lægemiddelpræparater til oral administration, såsom granulater, tabletter, gelatinekapsler eller drageer. - Google Patents

Fremgangsmåde til fremstilling af lægemiddelpræparater til oral administration, såsom granulater, tabletter, gelatinekapsler eller drageer.

Info

Publication number
DK112191B
DK112191B DK446164AA DK446164A DK112191B DK 112191 B DK112191 B DK 112191B DK 446164A A DK446164A A DK 446164AA DK 446164 A DK446164 A DK 446164A DK 112191 B DK112191 B DK 112191B
Authority
DK
Denmark
Prior art keywords
dragees
granules
tablets
preparation
pharmaceutical compositions
Prior art date
Application number
DK446164AA
Other languages
English (en)
Inventor
Hoffmann La Roche & Co Ag F
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of DK112191B publication Critical patent/DK112191B/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
DK446164AA 1963-09-10 1964-09-10 Fremgangsmåde til fremstilling af lægemiddelpræparater til oral administration, såsom granulater, tabletter, gelatinekapsler eller drageer. DK112191B (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH1115563 1963-09-10

Publications (1)

Publication Number Publication Date
DK112191B true DK112191B (da) 1968-11-18

Family

ID=4370622

Family Applications (1)

Application Number Title Priority Date Filing Date
DK446164AA DK112191B (da) 1963-09-10 1964-09-10 Fremgangsmåde til fremstilling af lægemiddelpræparater til oral administration, såsom granulater, tabletter, gelatinekapsler eller drageer.

Country Status (10)

Country Link
US (1) US3431338A (da)
BE (1) BE652807A (da)
BR (1) BR6462426D0 (da)
DE (1) DE1204363B (da)
DK (1) DK112191B (da)
ES (1) ES303909A1 (da)
FR (1) FR4213M (da)
GB (1) GB1017674A (da)
IL (1) IL21981A (da)
NL (1) NL6410434A (da)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1115596B (it) * 1978-03-13 1986-02-03 Bayer Italia Spa Metodo per la preparazione di microgranuli gastoresistenti ed enterosolubili di sostanze farmaceutiche,in particolare di sostanze proteiche e microgranuli preparati con detto metodo
FR2471186A1 (fr) * 1979-12-10 1981-06-19 Roussel Uclaf Nouveaux comprimes a delitescence colique, ainsi que leur procede de preparation
WO1981002671A1 (en) * 1980-03-20 1981-10-01 Ferring Farma Lab Pharmaceutical composition and method for the treatment of colitis ulcerosa and crohn's disease by oral administration
US4960765A (en) * 1980-03-20 1990-10-02 Farmaceutisk Laboratorium Ferring A/S Pharmaceutical composition and method for the treatment of colitis ulcerosa and Crohn's disease by oral administration
SE8003805L (sv) * 1980-05-21 1981-11-22 Haessle Ab En farmaceutisk beredning med forbettrade utlosningsegenskap
ZA825384B (en) * 1981-07-31 1983-05-25 Tillott J B Ltd Orally administrable pharmaceutical compositions
FR2532177A1 (fr) * 1982-08-30 1984-03-02 Being Well Products Inc Complement nutritionnel a zones de liberation determinees et son procede de fabrication
SE457505B (sv) * 1984-01-10 1989-01-09 Lejus Medical Ab Laminatbelagd oral farmaceutisk komposition och foerfarande foer dess framstaellning
IE59287B1 (en) * 1984-02-10 1994-02-09 Benzon Pharma As Diffusion coated multiple-units dosage form
DK62184D0 (da) * 1984-02-10 1984-02-10 Benzon As Alfred Diffusionsovertrukket polydepotpraeparat
US4668517A (en) * 1985-04-04 1987-05-26 Norwich Eaton Pharmaceuticals, Inc. Furazolidone dosage form
US4775536A (en) * 1986-02-24 1988-10-04 Bristol-Myers Company Enteric coated tablet and process for making
GB2189698A (en) 1986-04-30 1987-11-04 Haessle Ab Coated omeprazole tablets
US4857337A (en) * 1988-05-24 1989-08-15 American Home Products Corp. (Del) Enteric coated aspirin tablets
IT1230576B (it) * 1988-10-20 1991-10-28 Angeli Inst Spa Formulazioni farmaceutiche per via orale a liberazione selettiva nel colon
US4965089A (en) * 1989-04-10 1990-10-23 Sauter Manufacturing Corp. Method and apparatus for the gelatin coating of caplets
US5316772A (en) * 1990-12-19 1994-05-31 Solvay & Cie, S.A. (Societe Anonyme) Bilayered oral pharmaceutical composition with pH dependent release
US5914132A (en) * 1993-02-26 1999-06-22 The Procter & Gamble Company Pharmaceutical dosage form with multiple enteric polymer coatings for colonic delivery
US5651983A (en) * 1993-02-26 1997-07-29 The Procter & Gamble Company Bisacodyl dosage form for colonic delivery
US5843479A (en) * 1993-02-26 1998-12-01 The Procter & Gamble Company Bisacodyl dosage form with multiple enteric polymer coatings for colonic delivery
KR100388569B1 (ko) 1994-04-22 2003-10-11 야마노우치세이야쿠 가부시키가이샤 결장특이적약물방출용경구약제학적제제
US5637319A (en) * 1995-03-01 1997-06-10 Takada; Kanji Controlled-release preparations
US5686106A (en) * 1995-05-17 1997-11-11 The Procter & Gamble Company Pharmaceutical dosage form for colonic delivery
US6623759B2 (en) 1996-06-28 2003-09-23 Astrazeneca Ab Stable drug form for oral administration with benzimidazole derivatives as active ingredient and process for the preparation thereof
US20060116330A1 (en) * 1997-07-08 2006-06-01 The Iams Company Methods of mimicking the metabolic effects of caloric restriction by administration of mannoheptulose
US20020035071A1 (en) * 1997-07-08 2002-03-21 Josef Pitha Mimicking the metabolic effects of caloric restriction by administration of glucose antimetabolites
US8563522B2 (en) * 1997-07-08 2013-10-22 The Iams Company Method of maintaining and/or attenuating a decline in quality of life
US6296876B1 (en) 1997-10-06 2001-10-02 Isa Odidi Pharmaceutical formulations for acid labile substances
US8168170B2 (en) * 2002-10-03 2012-05-01 The Procter And Gamble Company Compositions having an inner core and at least three surrounding layers
EP2112920B1 (en) 2003-06-26 2018-07-25 Intellipharmaceutics Corp. Proton pump-inhibitor-containing capsules which comprise subunits differently structured for a delayed release of the active ingredient
RU2375048C2 (ru) * 2003-07-17 2009-12-10 Д-Р Редди'С Лабораторис Инк. Фармацевтическая композиция с набухающим покрытием
US7785635B1 (en) 2003-12-19 2010-08-31 The Procter & Gamble Company Methods of use of probiotic lactobacilli for companion animals
US8894991B2 (en) * 2003-12-19 2014-11-25 The Iams Company Canine probiotic Lactobacilli
US8877178B2 (en) 2003-12-19 2014-11-04 The Iams Company Methods of use of probiotic bifidobacteria for companion animals
US20050158294A1 (en) * 2003-12-19 2005-07-21 The Procter & Gamble Company Canine probiotic Bifidobacteria pseudolongum
US20050152884A1 (en) 2003-12-19 2005-07-14 The Procter & Gamble Company Canine probiotic Bifidobacteria globosum
US7670624B2 (en) * 2004-01-29 2010-03-02 Astella Pharma Inc. Gastrointestinal-specific multiple drug release system
US10624858B2 (en) 2004-08-23 2020-04-21 Intellipharmaceutics Corp Controlled release composition using transition coating, and method of preparing same
EP1885383B1 (en) * 2005-05-31 2016-09-21 IAMS Europe B.V. Feline probiotic bifidobacteria
WO2006130187A1 (en) * 2005-05-31 2006-12-07 The Iams Company Feline probiotic lactobacilli
US10064828B1 (en) 2005-12-23 2018-09-04 Intellipharmaceutics Corp. Pulsed extended-pulsed and extended-pulsed pulsed drug delivery systems
US10960077B2 (en) 2006-05-12 2021-03-30 Intellipharmaceutics Corp. Abuse and alcohol resistant drug composition
RU2309731C1 (ru) * 2006-09-29 2007-11-10 Исаак Григорьевич Гитлин Гранулят эметина гидрохлорида, способ его получения и лекарственная форма на его основе
MX2009008166A (es) 2007-02-01 2009-08-12 Iams Company Metodo para disminuir la inflamacion y estres en un mamifero usando antimetabolitos de glucosa, aguacate o extractos de aguacate.
US9771199B2 (en) 2008-07-07 2017-09-26 Mars, Incorporated Probiotic supplement, process for making, and packaging
US10104903B2 (en) 2009-07-31 2018-10-23 Mars, Incorporated Animal food and its appearance
WO2013035081A2 (de) 2011-09-07 2013-03-14 JÄNISCH, Melisa Optimale formulierung zur freisetzung eines wirkstoffes im dickdarm
US10653631B2 (en) 2011-09-07 2020-05-19 Roland SAUR-BROSCH Optimal colon targeting technology

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2957804A (en) * 1958-06-06 1960-10-25 Harlan R Shuyler Pesticide

Also Published As

Publication number Publication date
BE652807A (da) 1965-03-08
NL6410434A (da) 1965-03-11
GB1017674A (en) 1966-01-19
US3431338A (en) 1969-03-04
IL21981A (en) 1968-02-26
BR6462426D0 (pt) 1973-08-07
FR4213M (da) 1966-06-13
DE1204363B (de) 1965-11-04
ES303909A1 (es) 1965-07-16

Similar Documents

Publication Publication Date Title
DK112191B (da) Fremgangsmåde til fremstilling af lægemiddelpræparater til oral administration, såsom granulater, tabletter, gelatinekapsler eller drageer.
DK128053B (da) Fremgangsmåde til fremstilling af farmaceutiske kapsler af hydroxyalkylalkylcelluloseethere.
DK125957B (da) Fremgangsmåde til fremstilling af mavesaftresistente, tyndtarmopløselige gelatinekapsler.
DK132303B (da) Fremgangsmåde til fremstilling af en lægemiddelform med retarderende virkning.
DK125207B (da) Fremgangsmåde til fremstilling af dispersionsforstærkede zirconiumprodukter.
DK104194C (da) Fremgangsmåde til fremstilling af lægemidler i form af tabletter eller lignende smålegemer.
DK136246B (da) Fremgangsmåde til fremstilling af N-alkyl-1,4-dihydropyridiner.
DK127923B (da) Fremgangsmåde til fremstilling af maltitol.
DK116020B (da) Fremgangsmåde til fremstilling af farmaceutiske granulater, tabletter eller kapsler indeholdende antacidium, fyldstof og organopolysiloxan.
DK122789B (da) Fremgangsmåde til fremstilling af faste doseringsenheder, som hurtigt falder hen.
DK118301B (da) Fremgangsmåde til fremstilling af antitussive præparater, som indeholder dextromethorphan eller et salt deraf.
OA03402A (fr) Procédé de préparation de nouvelles compositions anthelminthiques.
DK140697B (da) Fremgangsmåde til fremstilling af 2-amino-4-hydroxy-6-hydroxymethyl-7,7-dimethyl-7,8-dihydropteridin.
DK134489B (da) Fremgangsmåde til fremstilling af alkyl-7-desoxy-7(S)-substituerede-alfa-thiolincosaminider.
DK128674B (da) Fremgangsmåde til fremstilling af tabletter indeholdende vandopløselige salte af α-carboxyester-substituerede phenylmethyl-penicilliner eller α-carboxyester-substituerede phenylmethyl-cephalosporiner til oral indgivning.
DK118420B (da) Fremgangsmåde til fremstilling af pressede tabletter.
DK122708B (da) Fremgangsmåde til fremstilling af farmaceutiske tabletter med langvarig virkning.
SE386074B (sv) Forfarande for granulering av pulverformiga tablettmassor
DK121922B (da) Fremgangsmåde til fremstilling af formede tabletter.
DK128496B (da) Fremgangsmåde til fremstilling af 5-fluoruracilderivater.
DK119255B (da) Fremgangsmåde til fremstilling af d- og 1-carnitinchlorid.
IL36285A0 (en) Erythromycylamine compounds,processes for preparation thereof and pharmaceutical compositions containing them
DK126504B (da) Fremgangsmåde til fremstilling af 1,2-disubstituerede 4-pyrazolidinoler.
DK125468B (da) Analogifremgangsmåde til fremstilling af piperazinium-mono-(acetylsalicylat).
FI52096C (fi) Menetelmä analgeettisesti aktiivisten 2,3-dihydrotiatsolo(3.2.a)pyrimi diini-5-onien valmistamiseksi